DD130352A5 - Verfahren zur herstellung von prostaglandin-derivaten - Google Patents
Verfahren zur herstellung von prostaglandin-derivatenInfo
- Publication number
- DD130352A5 DD130352A5 DD7700198124A DD19812477A DD130352A5 DD 130352 A5 DD130352 A5 DD 130352A5 DD 7700198124 A DD7700198124 A DD 7700198124A DD 19812477 A DD19812477 A DD 19812477A DD 130352 A5 DD130352 A5 DD 130352A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- production
- prostaglandine derivatives
- prostaglandine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL49325A IL49325A (en) | 1976-03-31 | 1976-03-31 | 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD130352A5 true DD130352A5 (de) | 1978-03-22 |
Family
ID=11048789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7700198124A DD130352A5 (de) | 1976-03-31 | 1977-03-29 | Verfahren zur herstellung von prostaglandin-derivaten |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4115401A (OSRAM) |
| JP (1) | JPS52142060A (OSRAM) |
| BE (1) | BE852941A (OSRAM) |
| CA (1) | CA1074804A (OSRAM) |
| CH (2) | CH624101A5 (OSRAM) |
| DD (1) | DD130352A5 (OSRAM) |
| DE (1) | DE2714129A1 (OSRAM) |
| ES (1) | ES457385A1 (OSRAM) |
| FR (1) | FR2346332A1 (OSRAM) |
| GB (1) | GB1574246A (OSRAM) |
| HU (1) | HU178040B (OSRAM) |
| IL (1) | IL49325A (OSRAM) |
| IT (1) | IT1075373B (OSRAM) |
| NL (1) | NL7703503A (OSRAM) |
| NO (1) | NO149428C (OSRAM) |
| PL (3) | PL108289B1 (OSRAM) |
| SE (1) | SE417603B (OSRAM) |
| SU (3) | SU676162A3 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU530907B2 (en) * | 1978-07-11 | 1983-08-04 | Glaxo Group Limited | Prostanoid compounds |
| US4320136A (en) * | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4456613A (en) * | 1982-12-27 | 1984-06-26 | E. I. Du Pont De Nemours And Company | 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof |
| US4530933A (en) * | 1982-12-27 | 1985-07-23 | E. I. Du Pont De Nemours And Company | 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents |
| AP2001002357A0 (en) | 1999-12-22 | 2001-12-31 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| SK5562003A3 (en) | 2000-11-27 | 2004-08-03 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
| JP2004521954A (ja) | 2001-07-16 | 2004-07-22 | エフ．ホフマン−ラ ロシュ アーゲー | Ｅｐ４受容体作用薬としてのプロスタグランジン類似体 |
| ES2289140T3 (es) * | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| EP1417975B1 (en) * | 2001-07-23 | 2011-03-02 | Ono Pharmaceutical Co., Ltd. | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| CN1653046A (zh) | 2002-03-05 | 2005-08-10 | 小野药品工业株式会社 | 8－氮杂前列腺素衍生化合物以及包含该化合物作为活性成分的药物 |
| AU2003209571A1 (en) * | 2002-03-18 | 2003-09-29 | Pfizer Products Inc. | Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
| JP2006515015A (ja) * | 2003-01-10 | 2006-05-18 | エフ．ホフマン−ラ ロシュ アーゲー | プロスタグランジンアゴニストとしての２−ピペリドン誘導体 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US20080058375A1 (en) * | 2004-01-08 | 2008-03-06 | Elworthy Todd R | 2-Piperidone derivatives as prostaglandin antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
-
1976
- 1976-03-31 IL IL49325A patent/IL49325A/xx unknown
-
1977
- 1977-03-28 BE BE176164A patent/BE852941A/xx not_active IP Right Cessation
- 1977-03-28 GB GB12991/77A patent/GB1574246A/en not_active Expired
- 1977-03-29 PL PL1977210102A patent/PL108289B1/pl unknown
- 1977-03-29 DD DD7700198124A patent/DD130352A5/xx unknown
- 1977-03-29 PL PL1977210101A patent/PL107544B1/pl unknown
- 1977-03-29 PL PL1977197005A patent/PL107643B1/pl unknown
- 1977-03-30 DE DE19772714129 patent/DE2714129A1/de not_active Withdrawn
- 1977-03-30 HU HU77LA913A patent/HU178040B/hu unknown
- 1977-03-30 NO NO771134A patent/NO149428C/no unknown
- 1977-03-30 SE SE7703698A patent/SE417603B/xx unknown
- 1977-03-30 CH CH400377A patent/CH624101A5/fr not_active IP Right Cessation
- 1977-03-30 CA CA275,134A patent/CA1074804A/en not_active Expired
- 1977-03-31 SU SU772465855A patent/SU676162A3/ru active
- 1977-03-31 FR FR7709650A patent/FR2346332A1/fr active Granted
- 1977-03-31 NL NL7703503A patent/NL7703503A/xx not_active Application Discontinuation
- 1977-03-31 JP JP3742877A patent/JPS52142060A/ja active Pending
- 1977-03-31 US US05/783,284 patent/US4115401A/en not_active Expired - Lifetime
- 1977-03-31 IT IT21906/77A patent/IT1075373B/it active
- 1977-03-31 ES ES457385A patent/ES457385A1/es not_active Expired
-
1978
- 1978-03-30 SU SU782594353A patent/SU837321A3/ru active
- 1978-03-30 SU SU782595450A patent/SU715019A3/ru active
-
1980
- 1980-09-17 CH CH697780A patent/CH628032A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL107544B1 (pl) | 1980-02-29 |
| SU837321A3 (ru) | 1981-06-07 |
| ES457385A1 (es) | 1978-02-01 |
| NL7703503A (nl) | 1977-10-04 |
| US4115401A (en) | 1978-09-19 |
| PL108289B1 (pl) | 1980-03-31 |
| BE852941A (fr) | 1977-09-28 |
| CH628032A5 (fr) | 1982-02-15 |
| HU178040B (en) | 1982-02-28 |
| FR2346332A1 (fr) | 1977-10-28 |
| FR2346332B1 (OSRAM) | 1980-05-09 |
| NO149428C (no) | 1984-04-18 |
| CH624101A5 (OSRAM) | 1981-07-15 |
| SU676162A3 (ru) | 1979-07-25 |
| IL49325A0 (en) | 1976-05-31 |
| PL107643B1 (pl) | 1980-02-29 |
| NO771134L (no) | 1977-10-03 |
| SE417603B (sv) | 1981-03-30 |
| GB1574246A (en) | 1980-09-03 |
| SU715019A3 (ru) | 1980-02-05 |
| SE7703698L (sv) | 1977-10-01 |
| CA1074804A (en) | 1980-04-01 |
| IL49325A (en) | 1979-11-30 |
| PL197005A1 (pl) | 1978-10-09 |
| NO149428B (no) | 1984-01-09 |
| DE2714129A1 (de) | 1977-10-13 |
| IT1075373B (it) | 1985-04-22 |
| JPS52142060A (en) | 1977-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD134224A5 (de) | Verfahren zur herstellung von substituierten aminosaeuren | |
| LU79385A1 (de) | Verfahren zur herstellung von morpholinderivaten | |
| AT353783B (de) | Verfahren zur herstellung von neuen pyrrolidin- -2-on-derivaten | |
| DD137235A5 (de) | Verfahren zur herstellung von androstan-oder androstan-17-on-derivaten | |
| AT373567B (de) | Verfahren zur herstellung von hochreinem elektroschmelzkorund | |
| DD130352A5 (de) | Verfahren zur herstellung von prostaglandin-derivaten | |
| ATA448177A (de) | Verfahren zur herstellung von neuen dipeptid- derivaten | |
| ATA432877A (de) | Verfahren zur herstellung von neuen dipeptid- derivaten | |
| DD132429A5 (de) | Verfahren zur herstellung von derivaten von phenoxyalkansaeuren | |
| AT357693B (de) | Verfahren zur herstellung von neuen ergolen- -derivaten | |
| AT347970B (de) | Verfahren zur herstellung von mehtyldichlor- phosphan | |
| ATA662376A (de) | Verfahren zur herstellung von terpolymerisaten | |
| DD130146A5 (de) | Verfahren zur herstellung von epoxyden | |
| AT352753B (de) | Verfahren zur herstellung von methyldichlor- phosphan | |
| AT358577B (de) | Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten | |
| AT349454B (de) | Verfahren zur herstellung von alfa-cyano- benzylestern | |
| ATA980876A (de) | Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden | |
| AT347929B (de) | Verfahren zur herstellung von triphenylalken- derivaten | |
| ATA121078A (de) | Verfahren zur herstellung von 17alpha- -alkinyl-androst-4-enderivaten | |
| DD132867A5 (de) | Verfahren zur herstellung von caprolactam | |
| DD129785A5 (de) | Verfahren zur herstellung von indazolderivaten | |
| AT351676B (de) | Verfahren zur herstellung von 7-alkoxy-3- chlormethyl-3-cephemen | |
| AT364919B (de) | Verfahren zur herstellung von bogentragwerken | |
| DD135485A5 (de) | Verfahren zur herstellung von nitroalkanolderivaten | |
| AT348506B (de) | Verfahren zur herstellung von bis- polybromphenoxy-alkanen |